Business Wire

SailPoint Lays Out Its Vision for the Next Frontier in Identity with IdentityAI

Jaa

During the company’s keynote session at Navigate ’17, SailPoint, the leader in enterprise identity management, shared the company’s plans to add artificial intelligence to its open identity platform, making identity-aware infrastructures smarter, more intelligent, and more responsive. To make this vision a reality, SailPoint previewed its new identity analytics solution, SailPoint IdentityAITM, which will provide customers with the visibility they need to understand the risk associated with user access, detect anomalous behavior which may be indicative of a breach, and to focus their governance controls to more efficiently and effectively manage identities.

According to SailPoint President and Co-founder Kevin Cunningham, “In cybersecurity, visibility is everything. Unfortunately, we are all too often blind to hackers’ actions until it’s far too late. Business managers lack the deep understanding and risk context needed to make critical access decisions, while security and operations teams struggle with a high number of ‘false positives.’ As a result, many breaches go undetected for extended periods of time, resulting in greater loss of data and financial exposure, subsequent customer churn and brand reputation damage,” said Cunningham. “What’s needed today is a tool that sorts through the incredible amount of identity data that security operations teams must ‘see through’ to detect a potential ongoing breach.”

“We can no longer accept this lack of visibility – the cost of undetected breaches and falling out of compliance is just too high,” continued Cunningham. “As both the regulatory and threat landscape evolve, so should the role of identity management. With IdentityAI, we’re delivering a solution that will allow customers to swiftly sift through the millions of bits of activity and access privileges to see what is truly happening on their network, long before any of their sensitive data winds up on the dark web. We believe identity analytics is the logical – and highly critical – next step in identity management’s evolution.”

“We believe that having visibility into user access is important, but perhaps even more important is the ability to turn that visibility into insights about high-risk users, access, and/or behaviors,” said Andrew Linn, SVP and Chief Information Officer for Orrstown Bank. “Such insights allow us to focus our controls on the riskiest and most likely scenarios to be abused by external attackers or rogue insiders. The challenge is that manually sifting through mountains of identity data to uncover these insights is impractical if not impossible. We believe that machine learning technology gives us the analytical power and speed to effectively sort through all of the ‘identity noise’ to find the insights that really add value. As such, we see significant value in adding IdentityAI to our identity governance program.”

SailPoint: Making Identity Smarter

By adding identity analytics to SailPoint’s open identity platform, SailPoint will enable customers to manage their identities smarter, boosting the impact of their existing identity governance program and better mitigating potential threats. SailPoint IdentityAI, available later this year, will extend the value of SailPoint’s open identity platform by allowing organizations to:

  • Manage Risk: IdentityAI detects and alerts on anomalous behaviors and potential threats using artificial intelligence technology to perform peer group analysis, behavioral pattern matching and statistical analysis. The machine learning analytics engine scans massive amounts of identity data to identify risks without having to rely on a team of security experts.
  • Govern Smarter: IdentityAI makes identity smarter by contextualizing and focusing identity governance controls on high risk scenarios and conditions, such as anomalous or inappropriate access events, by initiating automated governance actions in real-time.
  • Increase Efficiency: IdentityAI improves operational efficiency of the IT organization and business productivity by automating identity governance activities for routine and low-risk access.

“With the right intelligence, organizations can identify and mitigate risks as well as improve operational efficiency without requiring more from their already over-stretched IT staff. IdentityAI gives organizations a tool that tracks behavioral patterns over time and utilizes machine learning to highlight anomalies, quickly detecting an identity incident out of the norm and focusing controls on it,” said Kevin Cunningham. “By adding IdentityAI as an extension of our open identity platform, we’re giving customers the visibility they need to make their identity governance programs smarter and more powerful than ever before.”

SailPoint: The Power of Identity™

SailPoint, the leader in enterprise identity management, brings the Power of Identity to customers around the world. SailPoint’s open identity platform gives organizations the power to enter new markets, scale their workforces, embrace new technologies, innovate faster and compete on a global basis. As both an industry pioneer and market leader in identity governance, SailPoint delivers security, operational efficiency and compliance to enterprises with complex IT environments. SailPoint's customers are among the world’s largest companies in virtually every industry, including: 9 of the top banks, 7 of the top retail brands, 6 of the top healthcare providers, 6 of the top property and casualty insurance providers, and 6 of the top pharmaceutical companies.

Stay up-to-date on SailPoint by following us on Twitter and LinkedIn and by subscribing to the SailPoint blog.

SailPoint, the SailPoint logo, IdentityAI, IdentityIQ, IdentityNow, SecurityIQ and all techniques are trademarks or registered trademarks of SailPoint Technologies, Inc. in the U.S. and/or other countries. All other products or services are trademarks of their respective companies.

Contact information

SailPoint
Jessica Sutera, 978-278-5411
Jessica.sutera@sailpoint.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

New data presented at the American Academy of Dermatology show LEO Pharma’s Kyntheum® (brodalumab) improves psoriasis on the nail19.2.2018 09:00Tiedote

NOT FOR DISTRIBUTION IN THE UNITED STATES OR UNITED KINGDOM: LEO Pharma today announced new data demonstrating long-term improvements in psoriasis on the nail with Kyntheum® (brodalumab) when compared to placebo or ustekinumab.1 Psoriasis on the nail, which is challenging to treat,2 affects approximately half of the estimated 125 million people living with psoriasis worldwide.2,3 The data were presented at the 76th annual American Academy of Dermatology (AAD) meeting in San Diego, California, US. Psoriasis is a common, chronic, immune-mediated, inflammatory disease that primarily involves the skin, but also impacts emotional, psychological and physical health.4 The heavy and far-reaching burden of the disease can be disabling and stigmatising with a substantial negative impact on those affected and their families.4 Due to the visible nature of the condition, psoriasis on the nail can be particularly upsetting for patients.4 In moderate to severe cases, psoriasis on the nail can be pain

OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers18.2.2018 00:00Tiedote

Celgene Corporation (NASDAQ:CELG) today announced that data from the phase III RELIEF™ clinical trial of OTEZLA® (apremilast) in patients with active Behçet’s Disease with oral ulcers were presented in a late-breaking oral presentation at the 2018 American Academy of Dermatology (AAD) Annual Meeting. The results showed statistically significant reductions in oral ulcers with apremilast 30 mg twice daily (BID) versus placebo through week 12. OTEZLA (apremilast) is Celgene’s oral selective inhibitor of phosphodiesterase 4 (PDE4). Behçet’s Disease is a rare, chronic, multi-system inflammatory syndrome. Oral ulcers, the most common manifestation of Behçet’s Disease, can be disabling and have a substantial effect on quality of life. This study primarily evaluated the effect of apremilast on recurring oral ulcers in patients with active Behçet’s Disease who were previously treated with at least one topical or systemic medication. “Reducing oral ulcers, which are painful and can negatively im

CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study17.2.2018 11:00Tiedote

Twelve-month data from the Personalised Anti-TNF therapy in Crohn’s disease Study (PANTS) was presented at the 13th Congress of the European Crohn’s and Colitis Organisation (ECCO). The results indicate that the clinical effectiveness, safety and immunogenicity of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) in patients with Crohn’s disease (CD) is comparable to those treated with reference infliximab as well as those treated with adalimumab.1 The UK-wide, three-year prospective observational study investigated primary non-response (PNR), loss of response (LOR) and adverse drug reactions (ADR) to infliximab (reference infliximab and CT-P13) and adalimumab in 1610 CD patients. The data show comparable efficacy between CT-P13, reference infliximab and adalimumab in relation to PNR, LOR and ADR rates. In addition, at week 54, the remission rate was 39.7%, 39.0% and 32.7% for reference infliximab, CT-P13 and adalimumab treated patients, respectively.1 The PANTS study investigates

Avanti Communications HYLAS 4 Satellite Arrives in French Guiana16.2.2018 21:26Tiedote

Avanti Communications Group plc (“Avanti”), a leading provider of satellite data communications services in Europe, the Middle East and Africa (“EMEA”), announces its HYLAS 4 satellite has arrived safely in French Guiana ahead of its March 2018 launch. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005586/en/ Avanti Communications HYLAS 4 Satellite Arrives in French Guiana (Photo: Business Wire) The spacecraft, built by Orbital ATK was packed and shipped at their Satellite Manufacturing Facility in Dulles, Virginia, United States and flown to French Guiana, where it was unloaded and will be taken to the Arianespace launch facilities in Kourou. HYLAS 4 uses the latest High Throughput Satellite technology, doubling Avanti's Ka-band capacity across EMEA. The latest addition to Avanti's HYLAS fleet will provide: Backhaul services for mobile network operators Wholesale broadband for ISPs Connectivity for governments (civil a

General Cable Corporation Stockholders Approve Acquisition By Prysmian Group16.2.2018 20:05Tiedote

General Cable Corporation (NYSE: BGC) today announced the voting results from the Company’s special meeting of stockholders held this morning. Stockholders of General Cable approved the Company’s previously announced acquisition by Prysmian Group (BIT: PRY) for $30.00 per share in cash. A total of 38,140,754 shares, representing approximately 75.34% of the total number of shares of common stock outstanding and approximately 99% of the total votes cast, were voted in favor of the merger. Subject to regulatory approvals and other customary closing conditions, the transaction is expected to close by the third quarter of 2018. About General Cable General Cable (NYSE:BGC), with headquarters in Highland Heights, Kentucky, is a global leader in the development, design, manufacture, marketing and distribution of aluminum, copper and fiber optic wire and cable products for the energy, communications, automotive, industrial, construction and specialty segments. General Cable is one of the larges

Systemic Sclerosis World Congress:Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease16.2.2018 12:03Tiedote

Boehringer Ingelheim today unveils a new phase of 'More Than Scleroderma: The Inside Story', and launches the new patient website www.morethanscleroderma.com. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005188/en/ Anna, 36, living with scleroderma (Photo: Business Wire) The global initiative highlights the importance of understanding the ‘inside story’ of each individual living with scleroderma, also known as systemic sclerosis. To coincide with the Systemic Sclerosis World Congress in Bordeaux, 15-17 February 2018, new and truly inspiring patient stories are revealed, reflecting the real-life, diverse and very moving journeys of people living with scleroderma across the world. The campaign will also be launched in the U.S. The new website www.morethanscleroderma.com features a powerful collection of photographs and video stories of people living with scleroderma across the world, revealing the life-changing impact o

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme